Herko Grubitzsch

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Comparison of uncalibrated arterial waveform analysis in cardiac surgery patients with thermodilution cardiac output measurements

Michael Sander, Claudia Spies, Herko Grubitzsch et al. · Critical Care · 2006 · 121 citations · Full text

Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a randomised controlled trial

Henryk Dreger, Isabel Mattig, Bernd Hewing et al. · EuroIntervention · 2020 · 108 citations

Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial

Heribert Schunkert, Andreas Boening, Moritz von Scheidt et al. · European Heart Journal · 2019 · 84 citations · Full text

Impact of Gender on Three-Month Outcome and Left Ventricular Remodeling After Transfemoral Transcatheter Aortic Valve Implantation

Verena Stangl, Gerd Baldenhofer, Fabian Knebel et al. · The American Journal of Cardiology · 2012 · 83 citations

Heart Failure, Gender Identity, Medicine +9